About AmbioPharm
AmbioPharm is a company based in North Augusta (United States) founded in 2006.. AmbioPharm has raised $24 million across 2 funding rounds from investors including The Carlyle Group. AmbioPharm operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, Ocelot Bio, PolyPeptide and Maruho, among others.
- Headquarter North Augusta, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$24 M (USD)
in 2 rounds
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of AmbioPharm
AmbioPharm has successfully raised a total of $24M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(19 Nov 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2018 | Amount | Series B - AmbioPharm | Valuation | The Carlyle Group |
|
| Nov, 2014 | Amount | Series B - AmbioPharm | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AmbioPharm
AmbioPharm has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Carlyle Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AmbioPharm
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AmbioPharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ambiopharm Comparisons
Competitors of AmbioPharm
AmbioPharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, Ocelot Bio, PolyPeptide and Maruho, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Company specializing in development of Biosimilars
|
|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Ocelot Bio is a CDMO specializing in peptide manufacturing services.
|
|
| domain | founded_year | HQ Location |
Proprietary, GMP-grade, and non-GMP peptides are manufactured by PolyPeptide Labs.
|
|
| domain | founded_year | HQ Location |
Conducts R&D and manufactures ethical drugs for healthcare applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ambiopharm
Frequently Asked Questions about AmbioPharm
When was AmbioPharm founded?
AmbioPharm was founded in 2006 and raised its 1st funding round 8 years after it was founded.
Where is AmbioPharm located?
AmbioPharm is headquartered in North Augusta, United States. It is registered at North Augusta, South Carolina, United States.
Is AmbioPharm a funded company?
AmbioPharm is a funded company, having raised a total of $24M across 2 funding rounds to date. The company's 1st funding round was a Series B of $24M, raised on Nov 19, 2014.
What does AmbioPharm do?
AmbioPharm is the contract manufacturer of peptides and biopharmaceuticals which also offers GMP services like Peptide API production and non-GMP process development services like GLP-grade peptide supply for pre-clinical applications, custom peptides and non-peptidic small molecules for pre-clinical in-vitro, medicinal, and toxicology programs. It also provides vaccine development services for developing antigenic sequences, single antigens, Multi-Antigenic-Peptides (MAPS), and multiple peptide vaccine cocktails. In parallel, it also provides analytical and process development tools that monitor the process for side reactions, purity checks, API control and process minimization. The company also offers services for organic conjugation to small molecules, proteins, toxoids, antifungals, KLH, and PEG. They claim to have expertise in a wide range of halogenated chemicals, with core competencies in fluorination of APIs and advanced intermediates.
Who are the top competitors of AmbioPharm?
AmbioPharm's top competitors include Enzene Biosciences, Hybio Pharmaceutical and PolyPeptide.
Who are AmbioPharm's investors?
AmbioPharm has 1 investor. Key investors include The Carlyle Group.